Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence

被引：0
|
作者：
Kelly, C. [1 ]
Barnett, G. [2 ]
Iqbal, M. S. [3 ]
机构：
[1] Newcastle Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Hills Rd, Cambridge CB2 0QQ, England
[3] Newcastle Univ, Freeman Hosp, Newcastle Tyne Hosp NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, England
来源：
CLINICAL ONCOLOGY | 2024年 / 36卷 / 09期
关键词：
Chemotherapy; head and neck cancer; immunotherapy; pembrolizumab; SQUAMOUS-CELL CARCINOMA; OPEN-LABEL; CETUXIMAB; RECURRENT;
D O I：
10.1016/j.clon.2024.05.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：534 / 536
页数：3
相关论文
共 50 条
  • [41] Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer
    Spencer, S
    Wheeler, R
    Peters, G
    Meredith, R
    Beenken, S
    Nabel, L
    Wooten, A
    Soong, SJ
    Salter, M
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (02): : 118 - 122
  • [42] TIME-SEQUENTIAL CHEMOTHERAPY IN HEAD AND NECK (H+N) CANCER
    TEJADA, F
    MURPHY, E
    ZUBROD, CG
    CELL AND TISSUE KINETICS, 1980, 13 (06): : 670 - 671
  • [43] Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review)
    Diniz, Carlos Henrique De Paula
    Henrique, Tiago
    Stefanini, Ana Carolina B.
    De Castro, Tialfi Bergamin
    Tajara, Eloiza H.
    ONCOLOGY REPORTS, 2024, 51 (06)
  • [44] Five years survival outcomes of head and neck cancer patients treated with palliative metronomic chemotherapy.
    Naidu, Priyanka Dhanraj
    Patil, Vijay Maruti
    Noronha, Vanita
    Nawale, Kavita Prakash
    Dhumal, Sachin Babanrao
    Jogdhankar, Shweta
    Menon, Nandini Sharrel
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18009 - E18009
  • [45] Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)
    Wei, Chun
    Lan, Xiaojun
    Qiu, Maona
    Cui, Ran
    Fu, Qiuxia
    Shinge, Shafiu A. Umar
    Muluh, Tobias Achu
    Jiang, Ou
    ONCOLOGY LETTERS, 2023, 26 (03)
  • [46] Efficacy and Safety of Intro-Arterial Chemotherapy Combined with Radiotherapy on Head and Neck Cancer: A Systematic Review and Meta-Analysis
    Huang, Yan
    Wu, Li-Ling
    Xiang, Ruo-Lan
    Yu, Guang-Yan
    JOURNAL OF CANCER, 2019, 10 (25): : 6233 - 6243
  • [47] Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review
    Schutte, Henrieke W.
    Heutink, Floris
    Wellenstein, David J.
    van den Broek, Guido B.
    van den Hoogen, Frank J. A.
    Marres, Henri A. M.
    van Herpen, Carla M. L.
    Kaanders, Johannes H. A. M.
    Merkx, Thijs M. A. W.
    Takes, Robert P.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 162 (04) : 446 - 457
  • [48] Short-Course Palliative Radiotherapy Combined With Immunotherapy for Recurrent/Advanced/Metastatic Head and Neck Cancer
    Iyer, A.
    Steber, C.
    Porosnicu, M.
    Lycan, T.
    Johnson, A. G.
    Frizzell, B. A.
    Greven, K. M.
    Hughes, R. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E408 - E408
  • [49] First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
    Shunji Takahashi
    Nobuhiko Oridate
    Kaoru Tanaka
    Yasushi Shimizu
    Yasushi Fujimoto
    Koji Matsumoto
    Tomoya Yokota
    Tomoko Yamazaki
    Masanobu Takahashi
    Tsutomu Ueda
    Nobuhiro Hanai
    Hironori Yamaguchi
    Hiroki Hara
    Tomokazu Yoshizaki
    Ryuji Yasumatsu
    Masahiro Nakayama
    Kiyoto Shiga
    Takashi Fujii
    Kenji Mitsugi
    Kenichi Takahashi
    Nijiro Nohata
    Burak Gumuscu
    Ramona F. Swaby
    Makato Tahara
    International Journal of Clinical Oncology, 2022, 27 : 1805 - 1817
  • [50] First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
    Takahashi, Shunji
    Oridate, Nobuhiko
    Tanaka, Kaoru
    Shimizu, Yasushi
    Fujimoto, Yasushi
    Matsumoto, Koji
    Yokota, Tomoya
    Yamazaki, Tomoko
    Takahashi, Masanobu
    Ueda, Tsutomu
    Hanai, Nobuhiro
    Yamaguchi, Hironori
    Hara, Hiroki
    Yoshizaki, Tomokazu
    Yasumatsu, Ryuji
    Nakayama, Masahiro
    Shiga, Kiyoto
    Fujii, Takashi
    Mitsugi, Kenji
    Takahashi, Kenichi
    Nohata, Nijiro
    Gumuscu, Burak
    Swaby, Ramona F.
    Tahara, Makato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (12) : 1805 - 1817
12345